Connection

Patrick Randall to Humans

Back to Details
This is a "connection" page, showing publications Patrick Randall has written about Humans.
Patrick Randall
Connection Strength
0.265
Humans
  1. Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control. Alcohol Clin Exp Res. 2017 Jul; 41(7):1370-1380.
    View in: PubMed
    Score: 0.022
  2. Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry. 2011 Jul; 168(7):709-17.
    View in: PubMed
    Score: 0.014
  3. Appetitive nature of drug cues re-confirmed with physiological measures and the potential role of stage of change. Psychopharmacology (Berl). 2007 Oct; 194(2):253-60.
    View in: PubMed
    Score: 0.011
  4. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin. J Clin Sleep Med. 2007 Feb 15; 3(1):24-32.
    View in: PubMed
    Score: 0.011
  5. The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response. J Stud Alcohol. 2006 Sep; 67(5):700-6.
    View in: PubMed
    Score: 0.010
  6. Cold pressor task reactivity: predictors of alcohol use among alcohol-dependent individuals with and without comorbid posttraumatic stress disorder. Alcohol Clin Exp Res. 2006 Jun; 30(6):938-46.
    View in: PubMed
    Score: 0.010
  7. Unipolar depression, life context vulnerabilities, and drinking to cope. J Consult Clin Psychol. 2004 Apr; 72(2):269-75.
    View in: PubMed
    Score: 0.009
  8. Prospective relations between social support and depression: differential direction of effects for parent and peer support? J Abnorm Psychol. 2004 Feb; 113(1):155-9.
    View in: PubMed
    Score: 0.009
  9. Drinking to cope and alcohol use and abuse in unipolar depression: a 10-year model. J Abnorm Psychol. 2003 Feb; 112(1):159-65.
    View in: PubMed
    Score: 0.008
  10. Drinking to cope, emotional distress and alcohol use and abuse: a ten-year model. J Stud Alcohol. 2001 Mar; 62(2):190-8.
    View in: PubMed
    Score: 0.007
  11. Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial. Alcohol Clin Exp Res. 2020 10; 44(10):2084-2096.
    View in: PubMed
    Score: 0.007
  12. Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence. Alcohol Clin Exp Res. 2018 Apr; 42(4):751-760.
    View in: PubMed
    Score: 0.006
  13. Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial. Neuropsychopharmacology. 2018 05; 43(6):1247-1256.
    View in: PubMed
    Score: 0.006
  14. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology. 2017 Dec; 42(13):2640-2653.
    View in: PubMed
    Score: 0.005
  15. The Reasons for Heavy Drinking Questionnaire: Factor Structure and Validity in Alcohol-Dependent Adults Involved in Clinical Trials. J Stud Alcohol Drugs. 2016 Mar; 77(2):354-61.
    View in: PubMed
    Score: 0.005
  16. Effects of the benzodiazepine antagonist flumazenil in PTSD. Biol Psychiatry. 1995 Sep 01; 38(5):319-24.
    View in: PubMed
    Score: 0.005
  17. KCNN Genes that Encode Small-Conductance Ca2+-Activated K+ Channels Influence Alcohol and Drug Addiction. Neuropsychopharmacology. 2015 Jul; 40(8):1928-39.
    View in: PubMed
    Score: 0.005
  18. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals. Psychopharmacology (Berl). 2014 Sep; 231(18):3799-807.
    View in: PubMed
    Score: 0.004
  19. A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. Am J Addict. 2013 Sep-Oct; 22(5):443-52.
    View in: PubMed
    Score: 0.004
  20. Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):244-50.
    View in: PubMed
    Score: 0.004
  21. Treating individuals with social anxiety disorder and at-risk drinking: phasing in a brief alcohol intervention following paroxetine. J Anxiety Disord. 2013 Mar; 27(2):252-8.
    View in: PubMed
    Score: 0.004
  22. Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics. Psychopharmacology (Berl). 2013 Jun; 227(4):627-37.
    View in: PubMed
    Score: 0.004
  23. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacology. 2013 Feb; 38(3):414-22.
    View in: PubMed
    Score: 0.004
  24. Hair ethyl glucuronide is highly sensitive and specific for detecting moderate-to-heavy drinking in patients with liver disease. Alcohol Alcohol. 2013 Jan-Feb; 48(1):83-7.
    View in: PubMed
    Score: 0.004
  25. Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes. Alcohol Clin Exp Res. 2012 Nov; 36(11):2000-7.
    View in: PubMed
    Score: 0.004
  26. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence. Alcohol Clin Exp Res. 2011 Nov; 35(11):2030-8.
    View in: PubMed
    Score: 0.004
  27. Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach. Neuroimage. 2011 May 01; 56(1):61-8.
    View in: PubMed
    Score: 0.004
  28. An acute psychosocial stressor increases drinking in non-treatment-seeking alcoholics. Psychopharmacology (Berl). 2011 Nov; 218(1):19-28.
    View in: PubMed
    Score: 0.004
  29. An acute psychosocial stressor does not potentiate alcohol cue reactivity in non-treatment-seeking alcoholics. Alcohol Clin Exp Res. 2011 Mar; 35(3):464-73.
    View in: PubMed
    Score: 0.003
  30. The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. J Clin Psychopharmacol. 2010 Aug; 30(4):365-72.
    View in: PubMed
    Score: 0.003
  31. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study. Alcohol Clin Exp Res. 2010 Oct; 34(10):1803-12.
    View in: PubMed
    Score: 0.003
  32. Phosphatidylethanol and alcohol consumption in reproductive age women. Alcohol Clin Exp Res. 2010 Mar 01; 34(3):488-92.
    View in: PubMed
    Score: 0.003
  33. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009 Aug; 29(4):334-42.
    View in: PubMed
    Score: 0.003
  34. Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol Alcohol. 2009 Sep-Oct; 44(5):464-7.
    View in: PubMed
    Score: 0.003
  35. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009 Sep; 33(9):1582-8.
    View in: PubMed
    Score: 0.003
  36. Social anxiety impacts willingness to participate in addiction treatment. Addict Behav. 2009 May; 34(5):474-6.
    View in: PubMed
    Score: 0.003
  37. COMT genotype influences the effect of alcohol on blood pressure: results from the COMBINE study. Am J Hypertens. 2009 Jan; 22(1):87-91.
    View in: PubMed
    Score: 0.003
  38. Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study. Addiction. 2008 Oct; 103(10):1622-8.
    View in: PubMed
    Score: 0.003
  39. Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control. Alcohol Clin Exp Res. 2008 Nov; 32(11):1954-61.
    View in: PubMed
    Score: 0.003
  40. Treatment of social anxiety with paroxetine: mediation of changes in anxiety and depression symptoms. Compr Psychiatry. 2009 Mar-Apr; 50(2):135-41.
    View in: PubMed
    Score: 0.003
  41. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology. 2008 Jul; 248(1):97-105.
    View in: PubMed
    Score: 0.003
  42. Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry. 2008 Apr; 65(4):466-75.
    View in: PubMed
    Score: 0.003
  43. Improving acceptance of naltrexone in community addiction treatment centers: a pilot study. J Subst Abuse Treat. 2008 Oct; 35(3):260-8.
    View in: PubMed
    Score: 0.003
  44. A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking? Alcohol Clin Exp Res. 2008 Jan; 32(1):77-84.
    View in: PubMed
    Score: 0.003
  45. Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder. J Anxiety Disord. 2008; 22(2):310-8.
    View in: PubMed
    Score: 0.003
  46. Patterns of gene expression in the frontal cortex discriminate alcoholic from nonalcoholic individuals. Neuropsychopharmacology. 2006 Jul; 31(7):1574-82.
    View in: PubMed
    Score: 0.002
  47. Effect of duration of haloperidol treatment on DA receptor supersensitization in aging C57BL/6J mice. Brain Res. 1985 Apr 29; 333(1):85-95.
    View in: PubMed
    Score: 0.002
  48. The relationship between women's subjective and physiological sexual arousal. Psychophysiology. 2005 Jan; 42(1):116-24.
    View in: PubMed
    Score: 0.002
  49. Gene expression profiling of individual cases reveals consistent transcriptional changes in alcoholic human brain. J Neurochem. 2004 Sep; 90(5):1050-8.
    View in: PubMed
    Score: 0.002
  50. Body image and eating disturbances across ethnic groups: more similarities than differences. Psychol Addict Behav. 2004 Mar; 18(1):12-8.
    View in: PubMed
    Score: 0.002
  51. Methods for the identification of differentially expressed genes in human post-mortem brain. Methods. 2003 Dec; 31(4):301-5.
    View in: PubMed
    Score: 0.002
  52. Aging and the regulation of striatal dopaminergic mechanisms in mice. J Pharmacol Exp Ther. 1981 Dec; 219(3):695-700.
    View in: PubMed
    Score: 0.002
  53. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse--a preliminary report. Biol Psychiatry. 1997 Jan 01; 41(1):23-32.
    View in: PubMed
    Score: 0.001
  54. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry. 1995 Jul; 152(7):973-81.
    View in: PubMed
    Score: 0.001
  55. Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. J Nucl Med. 1995 Feb; 36(2):167-75.
    View in: PubMed
    Score: 0.001
  56. Retrograde amnesia produced by hypothermia in rats. J Comp Physiol Psychol. 1968 Dec; 66(3):618-22.
    View in: PubMed
    Score: 0.001
  57. Genotypic influences on striatal dopaminergic regulation in mice. Brain Res. 1981 Apr 06; 210(1-2):201-15.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.